Auph short interest.

Live Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH Mar 24, 2023 · Aurinia's Q4, 2022 earnings call, (the "Call"), delivered on 02/28/2023, provides a report on how Aurinia is doing a full two years on. During the Call CEO Greenleaf advised that Aurinia was ... Aurinia Pharma ( NASDAQ: AUPH) is scheduled to announce Q3 earnings results on Thursday, November 2nd, before market open. The consensus EPS Estimate is -$0.17 vs -$0.06 in 3Q22 and the consensus ...Track Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsIn an ideal world, we would all find a way to make our money that is sitting in our banks work for us rather than, well, just sit there. One of the ways we can do that is by placing our money in accounts that offer a decent Annual Percentag...

AUPH has hovered mostly in the $13's and with a few short lived high's in the $14's and $15's. Has had some pretty volatile swings in single day trading periods.AUPH - Short squeeze stock short interest data and short selling information for shares of Aurinia Pharmaceuticals Ord. Short interest stock data available for NASDAQ, NYSE, AMEX, OTCBB and Pink Sheets stocks available from shortsqueeze.com.

Short Interest : 17.19M: Short Previous Month : 17.28M: Short % of Shares Out : 11.97%: Short % of Float : 12.21%: Short Ratio (days to cover) 11.64

Sep 30, 2023 · Net amortization of premiums and discounts on short-term investments (8,836) (14) Share-based compensation expense: 33,543 25,398 Write-down of inventory: 916 2,464 Other, net (3,910) 601 Net changes in operating assets and liabilities: Accounts receivable, net (24,463) (26,356) Inventories, net (8,984) (8,458) Prepaid expenses and other ... About Aurinia Pharmaceuticals Stock (TSE:AUP) Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license ...Biocept, Inc. (NASDAQ:BIOC – Get Free Report) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totalling 26,500 shares, a decline of 6.7% from the June 30th total of 28,400 shares. Approximately 1.8% of the company’s stock are sold short. Based on an average […]WebBiogen has more recently been seen as a potential acquirer of AUPH after a Stat News report said that Biogen is working with Goldman Sachs to find potential targets for the company. Aurinia ( AUPH ...

About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling ...

AUPH: Aurinia favored at Cantor despite earnings miss • 2:25 PM. Aurinia Pharmaceuticals (AUPH -18.2%) has plunged after the company’s Q1 financials came below expectations.It seems like the purpose of the document is to formalize the recent changes to the commercial partnership (originally announced here) as well as some of the items from the cooperation agreement released in February; particularly when it comes to the availability of stock warrants that Healios can execute once they achieve approvals for ARDS ... Get the latest SCYNEXIS Inc (SCYX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.AUPH Earnings Date and Information. Aurinia Pharmaceuticals last issued its quarterly earnings data on November 2nd, 2023. The biotechnology company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.08. The company had revenue of $54.52 million for the quarter, compared to the consensus estimate of $38 ...Author: u/Yolteotl (Karma: 16452, Created: Feb-2013). AUPH: Best treatment against Lupus nephritis, still widely undervalued, buyout candidate and…Finding the right furnished short term rental can be a daunting task. With so many options available, it can be difficult to know which one is best for you. Here are some tips to help you make the right choice when selecting a furnished sho...AUPH Short Interest Back to AUPH Overview NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on...

E131: 2024 Fantasy President picks, debt ceiling agreement, Dollar dominance & moreWebCantor Fitzgerald Reiterates Aurinia Pharmaceuticals (AUPH) Overweight Recommendation. ... Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand.Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results Business Wire - Thu May 4, 5:00AM CDT. Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for first quarter ended March 31, 2023. Amounts are expressed in U.S. dollars. 9.28. Frequency Therapeutics (NASDAQ:FREQ – Get Rating) and Appili Therapeutics (OTCMKTS:APLIF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and …WebAurinia Pharmaceuticals posted its second quarter numbers on August 3rd. The company posted a GAAP loss of 8 cents a share, more than a dime a share better than expectations. Revenues rose 47% on ...Overview of financial data and news for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH

The largest shareholder of Aurinia Pharmaceuticals ( NASDAQ: AUPH) said it plans to withholder support for seven board members at the company's upcoming annual meeting. Iljin SNT, which has a 6.1% ...

AUPH has a market cap of $1.3bn and a cash balance of $389mn. Research and development expenses were USD 9.9 million for 4Q. Selling, general and administrative expenses, inclusive of share-based ...We would like to show you a description here but the site won’t allow us.Find out why interest in selling AUPH stock has not subsided in some quarters. ... @PITX3 not really great short squeeze potential, more like short caress. 11% of float takes 5 ...Interest Coverage Financials. AUPH's profit margin has increased... subscribe to Premium to read more. Profit Margin Growth Financials. ... AUPH's cash and short-term investments... subscribe to Premium to read more. Debt Coverage Financials. AUPH vs Biotech Stocks. Ticker Market Cap 1d % P/E P/B; AUPH: $1.18B +4.44%-15.53x:The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...Still, when we talk about a small-cap biotech that is clearly drawing the interest of some big pharma guys, we can say that AUPH's current valuation is very low, without but surely with buyout ...Frequency Therapeutics (NASDAQ:FREQ – Get Rating) and Appili Therapeutics (OTCMKTS:APLIF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and …Web

Affimed saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 1,640,000 shares, a decline of 24.1% from the October 31st total of 2,160,000 shares. Based on an average daily volume of 562,700 shares, the short-interest ratio is currently 2.9 days. View Affimed's Short Interest.

2021-12-28 Short sale volume (not short interest) for $FSR is 66%. http://shortvolumes.com/?t=FSR $KDP 44% $TNA 40% $SPDW 77% $AUPH 41%. 29 Dec 2021Web

Sep 21, 2023 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ... On today's stock market, AUPH stock toppled 9.4% to 10.49. The hirings likely cooled investors' expectations that Aurinia could be looking for a buyout. In late 2021, reports suggested Bristol ...WebInitially, Lupkynis seemed to be a promising treatment for LN, but its adoption has fallen short of expectations, as shown by Aurinia's failure to meet its 2022 revenue projections ($115-$135 ...AUPH Short Interest Back to AUPH Overview NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on...29 Sep 2021 ... We follow 790 shorted U.S. domestic biotech stocks with total short interest of $54.5 billion. Short selling in these stocks is highly ...Analyst’s Disclosure: I/we have a beneficial long position in the shares of AUPH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my ...Mar 2, 2022 · Despite upbeat remarks from its chief executive ahead of the earnings, Aurinia’s (NASDAQ:AUPH) 2022 sales guidance fell short of expectations as net revenue for the year dropped ~9% YoY to $45 ... AUPH short interest is 12%. More on Aurinia. Aurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock Value; Aurinia Pharmaceuticals: All In On Lupkynis - A Tough Bet;View the basic AUPH option chain and compare options of Aurinia Pharmaceuticals Inc. on Yahoo Finance. ... Open Interest Implied Volatility; AUPH231215P00005000: 2023-11-15 12:00PM EST: 5.00: 0.04 ...WebAs a student, you need to stretch every dollar you have. The good news is there are many banks that help students grow their income by offering high interest rates on their savings.Meanwhile, Jefferies analyst Maury Raycroft, with a Buy rating on Aurinia ( AUPH ), has cut the per share target to $29 from $34 to imply a premium of ~142% to the last close. Raycroft attributes ...A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DAWN shares currently have a short interest ratio of 15.0. Learn More on Day One Biopharmaceuticals's short interest ratio.

Arrow Financial Co. (NASDAQ:AROW – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 153,000 shares, an increase of 13.1% from the February 28th total of 135,300 shares. Based on an average trading volume of 34,700 shares, the […]WebThe main competitors of U.S. Physical Therapy include InnovAge (INNV), DocGo (DCGO), Sharecare (SHCR), LifeStance Health Group (LFST), Privia Health Group (PRVA), Vir Biotechnology (VIR), Alignment Healthcare (ALHC), AbCellera Biologics (ABCL), Aurinia Pharmaceuticals (AUPH), and Disc Medicine (IRON). These companies are all part of the ...Jun 30, 2023 · Based on recent acquisitions, Aurinia ( AUPH) would be more likely to see $18–$20 per share in a takeover, RBC analyst Douglas Miehm, who has an outperform rating with a $13 price target on AUPH ... Instagram:https://instagram. carbon capture companyfidelity total bondtop brokers in canadalcut Live Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPHAurinia Pharmaceuticals Stock (NASDAQ:AUPH), Short Interest Report. Short interest for Aurinia Pharmaceuticals gives investors a sense of the degree to … self employed home lendersally stock trading Aurinia Pharmaceuticals (NASDAQ: AUPH) is trading ~2.5% higher in the pre-market after Oppenheimer raised its recommendation on the stock to Outperform from Perform. The price target of $31 per ... wade pfau Track Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Short Interest. Percentage of Shares Shorted 6.91% of the float of ESSA Pharma has been sold short. Short Interest Ratio / Days to Cover ESSA Pharma has a short interest ratio ("days to cover") of 7.8. Change versus previous month Short interest in ESSA Pharma has recently increased by 1.47%, indicating that investor sentiment is …WebA high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …